IP Library Granted Patent US 9,033,933
Granted Patent B2
US 9,033,933 · App. 13/576,633 · Granted May 19, 2015

Medicated module with lockable needle guard

Inventors: Malcolm Stanley Boyd (Wellsbourne, GB); James Alexander Davies (Leamington Spa, GB); Daniel Thomas De Sausmarez Lintell (Rugby, GB)
Assignee: SANOFI-AVENTIS DEUTSCHLAND GMBH
A61M5/3294A61M5/24A61M5/2448A61M5/3146A61M5/3257
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,033,933
App. No.
13/576,633
Granted
May 19, 2015
Kind
B2
Abstract

A medicated module for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device containing a primary medicament accepts a medicated module containing a single dose of a secondary medicament and where both medicaments are delivered through a single hollow needle. The medicated module is configured so that it will first deliver both the primary and secondary medicaments and then, if needed, a dose(s) of additional primary medicament. The module also contains a needle guard that locks the first dose delivery, but can be manually overridden by a user to perform a second or subsequent injection of primary medicament.

Claims (22)

1. A medicated module attachable to a drug delivery device, wherein the drug delivery device comprises a primary reservoir of medicament and a distal end with first attachment means, wherein the medicated module comprises a second medicament, the medicated module having a proximal end and a distal end and further comprising:

a. second attachment means at the proximal end for attachment to the first attachment means of the drug delivery device;

b. a second reservoir containing the second medicament;

c. a cavity containing the second reservoir and a proximal needle cannula configured to provide fluid communication with the primary reservoir when the medicated module is connected thereto and a distal injection needle cannula, the second reservoir being arranged in the axial direction between the proximal and the distal needle cannula, and the proximal and distal needle cannula being configured to allow fluid communication with the second reservoir,

d. a needle guard to provide protection against the injection needle cannula arranged in a portion of the medicated module and configured to move in an axial direction during application to an injection site;

e. a guard lock for at least temporarily disabling axial movement of the needle guard; and

f. a release mechanism operably connected to the guard lock for unlocking the guard lock such that axial movement of the needle guard is enabled.

2. The medicated module of claim 1 , where the release mechanism comprises a button accessible to a user to move the button to unlock the guard lock to enable axial movement of the needle guard.

3. The medicated module of claim 1 , where the guard lock comprises a rotating sleeve operably connected to the needle guard.

4. The medicated module of claim 1 , wherein when the needle guard is removed or withdrawn from the patient it is configured to return to a position covering the injection needle, wherein the guard lock is configured to lock the needle guard from further axial movement when the needle guard has returned to the position covering the injection needle.

5. The medicated module of claim 1 , where the activation of the release mechanism unlocks the guard lock to allow one or more additional retractions of the needle guard after dispensing the medicament and where after each retraction the guard lock at least temporarily locks the needle guard from axial movement.

6. The medicated module of claim 1 , configured such that after a predefined number of retractions of the needle guard the needle guard is permanently locked from axial movement such that unlocking is disabled.

7. The medicated module of claim 1 , where the second reservoir contains a movable bung dividing the second reservoir into a distal volume and a proximal volume.

8. The medicated module of claim 7 , where the bung separates a single dose of secondary medicament in the proximal volume from a fixed amount of primary medicament in the distal volume.

9. The medicated module of claim 7 configured such that when the medicament from the primary reservoir flows into the proximal volume the bung is caused to move into the distal volume, thereby expelling medicament from the distal volume, and configured such that the medicament in the proximal volume is dispensable around the bung when the bung is in the distal volume position.

10. The medicated module of any of claim 1 , comprising indicia for indicating an injection status of the drug delivery device.

11. The medicated module according to claim 1 , where a fluid path is defined in the cavity bypassing the second reservoir.

12. The medicated module according to claim 1 , where the second reservoir is a capsule sealed with top and bottom septa and where the capsule is positioned such that it is not in fluid communication with the distal and proximal needle cannula prior to retraction of the needle guard.

13. The medicated module of claim 1 , where the second reservoir contains a liquid medicament.

14. A drug delivery system to deliver two or more medicaments comprising a medicated module according to claim 1 and further comprising:

a primary reservoir of medicament containing at least one drug agent; where

the medicated module is configured for fluid communication with the primary reservoir.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2012
From: BOYD, MALCOLM STANLEY; DAVIES, JAMES ALEXANDER; DE SAUSMAREZ LINTELL, DANIEL THOMAS
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 029489/0038 →
Priority Claims (1)
EP 10160845.3 · Apr 23, 2010 · regional
Continuity (2)
Provisional Application 61301708 · Feb 5, 2010
Related Publication 20130110050A1 · May 2, 2013